Search - tctmd.com

Displaying 601 - 620 of 916

Sort: Relevancy | Date

Presentation TCT 2016

Announcing the NIH-sponsored HYBRID Revascularization Trial

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Presenter: John D. Puskas, Gregg W. Stone

November 01, 2016

Presentation TCT 2016

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

Presenter: John D. Puskas, Gregg W. Stone, John S. Douglas Jr

November 01, 2016

Presentation TCT 2016

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek

November 01, 2016

Presentation TCT 2016

Long Term Outcomes after Revascularization of Long SFA Occlusions with OCT Guided Atherectomy OCELOT Catheter: Results from the Pivotal FIH Study

Presenter: Michael D. Dake, Kenneth Rosenfield, Przemek Nowakowski

November 01, 2016

Presentation TCT 2016

The Impact of Ventricular Dysfunction on Prognosis After Coronary Revascularization

Presenter: Ulrich P. Jorde, William W. O'Neill, Eric Jose Velazquez

October 31, 2016

Presentation TCT 2016

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Presenter: Seung-Jung Park, Alan C. Yeung, Jung-Min Ahn

October 31, 2016

Presentation TCT 2016

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Coronary Revascularization in Severe Heart Failure: STICH and Beyond

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Robert E. Michler

October 31, 2016

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only?

Presenter: Ran Kornowski, Michel R. Le May, Henning Kelbæk

October 31, 2016

Presentation TCT 2016

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Michael J. Cowley, Franz-Josef Neumann, Shunsuke Kubo

October 31, 2016

Presentation TCT 2016

TCT 63: Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction

Presenter: Julinda Mehilli, Georgios Sianos, Philippe Généreux

October 31, 2016

Presentation TCT 2016

TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on Target Lesion Revascularization

Presenter: Nicolas Foin, Giampaolo Niccoli

October 31, 2016

Presentation TCT 2016

TCT 515: Prognostic Implications of Instantaneous Wave-Free Ratio (iFR) and Resting Distal-to-Aortic Pressure Ratio (Pd/Pa) Compared with Fractional Flow Reserve (FFR). A 10-Year Follow-Up Study After Deferral of Revascularization

Presenter: Michalis Hamilos, Pim A.L. Tonino

October 30, 2016

Presentation TCT 2016

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

Presenter: Jung-Min Ahn

October 30, 2016

Presentation TCT 2016

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Presentation TCT 2016

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry

Presenter: Warren J. Cantor, Thomas D. Stuckey

October 30, 2016

Advertisement

Announcing the NIH-sponsored HYBRID Revascularization Trial

Hybrid Coronary Revascularization: Results to Date (From Meta-analysis to the NIH Multicenter Observational Study)

Hybrid Coronary Revascularization: Rationale, Procedure Alternatives, and Technical Considerations

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Long Term Outcomes after Revascularization of Long SFA Occlusions with OCT Guided Atherectomy OCELOT Catheter: Results from the Pivotal FIH Study

The Impact of Ventricular Dysfunction on Prognosis After Coronary Revascularization

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus

Coronary Revascularization in Severe Heart Failure: STICH and Beyond

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Multivessel CAD in STEMI Patients With Shock: Complete Revascularization or Culprit Only?

TCT 52: Proportion and Morphological Features of Restenosis Lesions With Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

TCT 63: Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction

TCT 317: Ten-Year Impact of Stent Fracture and Peri-Stent Contrast staining After Sirolimus-Eluting Stent Implantation on Target Lesion Revascularization

TCT 515: Prognostic Implications of Instantaneous Wave-Free Ratio (iFR) and Resting Distal-to-Aortic Pressure Ratio (Pd/Pa) Compared with Fractional Flow Reserve (FFR). A 10-Year Follow-Up Study After Deferral of Revascularization

TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned?

Mortality of Stenting vs Bypass Surgery According to Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials

TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease

TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content